Short-term efficacy of nicotine replacement therapy (NRT) for smoking cessation among adolescents and the role of compliance Charlotte Scherphof* Regina.

Slides:



Advertisements
Similar presentations
Jean-François ETTER Evelyne LASZLO Jean-Pierre ZELLWEGER Charles PERROT Thomas PERNEGER University of Geneva, Switzerland Smoking reduction with NRT: a.
Advertisements

Pre-cessation nicotine treatment Jean-François ETTER Dr polit. sci, privat docent Institute de Médicine Sociale et Préventive Faculté de Médecine, Université.
The Novice User’s Experience of the Titan 510 Electronic Cigarette: a Mixed Methods Approach Victoria Lawson, Sharon Cahill & Lynne Dawkins School of Psychology,
Effectiveness Of Nurse-clinician Led Smoking Cessation Clinic In Singapore Effectiveness Of Nurse-clinician Led Smoking Cessation Clinic In Singapore PRABHAKARAN.
Positive smoker identity as a barrier to quitting smoking: Findings from a national survey of smokers in England Ildiko Tombor, Lion Shahab, Jamie Brown,
LECTURE 8 HYPOTHESIS TESTING AND STATISTICAL SIGNIFICANCE MSc (Addictions) Addictions Department.
Nicotine Replacement Therapy: Administration and Overview Barbara Hart, MPA and Claudia Lechuga, MS Bronx BREATHES T: (718) E:
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2015.
1 CTRI Webinar: Combination Medication Effectiveness June 9, 2010 Stevens S. Smith, Ph.D. Megan E. Piper, Ph.D. Center for Tobacco Research & Intervention.
Smoking Cessation in Smokers Motivated to Quit Presented at American College of Cardiology Scientific Sessions 2004 Presented by Dr. Robert Anthenelli.
TREATING SPECIAL POPULATIONS. OVERVIEW Tobacco Treatment Smoking Outcomes Co-occurring Disorders Integration Tobacco Prevention.
BELLARMINE UNIVERSITY, LOUISVILLE, KY Electronic Cigarettes and Smoking Cessation Sarah Boone, Carolyn Little, Clay Owens, Jeremy Randolph, Genny Tibbs.
Smoking Cessation for Pregnancy and Beyond: Virtual Clinic Companion Slides Catherine A. Powers, EdD, LSW PACE – Tobacco Prevention and Cessation Education.
Smoking cessation outcomes of an intensive tobacco treatment program within mental health and addictions services Chizimuzo Okoli, PhD, MPH, RN Director,
Journal Club Sidharth Bagga MD. Cytisus laborium L. (Golden rain acacia)
PATHFINDER CASE STUDY TOBACCO CONTROL. Points to ponder This is a model, not a definitive analysis Does this model reflect the way outcome is attributed.
Real-world effectiveness of nicotine replacement therapy in pregnancy Leonie S. Brose, PhD Andy McEwen, PhD & Robert West, PhD University College London.
Clinical trial 2. Objective To evaluate efficacy and safety of varenicline for smoking cessation compared with sustained-release bupropion (bupropion.
Prevention strategies and treatments HANEWINKEL AND WIBORG DAVIS ET. AL Claire Evenson, Niveda Ganesh, Nadia McCloskey, and Heather Purchas.
Norwich Medical School Faculty of Medicine and Health Science Longer-Term Smoking Abstinence after treatment by specialist or non-specialist advisors:
Can undergoing an internet based ACT intervention change the impact of predictors thought to lead to Substance Use? Leonidou. G., Savvides. S., N. & Karekla.
Effect of Depression on Smoking Cessation Outcomes Sonne SC 1, Nunes EV 2, Jiang H 2, Gan W 2, Tyson C 1, Reid MS 3 1 Medical University of South Carolina,
Thoughts emerging from ITC project about cessation assistance Ron Borland PhD Ron Borland PhD.
Background Background The municipality of Teylingen asked the Academic Workplace Public Health to investigate the background of the alcohol use of their.
Hazel Gilbert Research Department of Primary Care and Population Health UCL Medical School Can we involve smokers who are unmotivated to quit in quitting.
Nicotine Dependence: Comparing Menthol and Non-Menthol Cigarette Smokers Qiang Li, MS Andrew Hyland, PhD Gary Giovino, MS, PhD Joseph Bauer, PhD Michael.
ABSTINENCE AND RELAPSE AMONG SMOKERS WHO USE VARENICLINE FOR QUITTING—A POOLED ANALYSIS OF RANDOMIZED CONTROLLED TRIALS Shade Agboola, Ann McNeill, Tim.
OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: Racial/ethnic differences Lirio S. Covey, 1 Mei-Chen Hu,
Nicotine dependence It’s in ICD 10! MRCPsych addiction psychiatry seminars March 2010.
What is the Most Effective Way to Kick the Nastiest, Filthiest Habit? A Presentation for Psychology 2023 By Tara Ricketts & Paul Todd.
Prepared by: Dr. Mohammad Shaikhani University of Sulaimani College of Medicine. Dept of Medicine.
Clinical trial 2. Objective To evaluate efficacy and safety of varenicline for smoking cessation compared with sustained-release bupropion (bupropion.
SMOKING in ADOLESCENTS with PSYCHIATRIC or ADDICTIVE DISORDERS.
1 Impact of Depression History on Tobacco Withdrawal and Relapse Among Female Smokers David W. Wetter, Ph.D. Department of Behavioral Science Funded by.
“Comparing Two web-based Smoking Cessation Programs: Randomized- Controlled Trial” By: McKay et. Al.
Factors associated with health care providers’ practice of smoking cessation interventions in public health facilities in Kiambu County, Kenya Dr Judy.
E of computer-tailored S moking C essation A dvice in P rimary car E ffectiveness Hazel Gilbert, Irwin Nazareth and Richard Morris Department of Primary.
Ten Years of Pharmacotherapy Trials in the CTN: An Overview.
The Role of Close Family Relationships in Predicting Multisystemic Therapy Outcome: An Investigation of Sex Differences ABSTRACT BACKGROUND: Multisystemic.
What the National Institute on Drug Abuse’s Clinical Trials Network Can Do for You? Major Findings from Medication Trials and Implications for Community-Based.
Efficacy of Combination First Line Agents for Smoking Cessation Sneha Baxi, Pharm.D. Pharmacy Practice Resident University of Illinois at Chicago.
-Tobacco is the leading preventable cause of disease, disability, and death in the United States (NIDA, 2012). -About 1 in every 5 deaths in the U.S. result.
CAPSTONE PROJECT. Setting the scene- why smoking cessation is important in the treatment of COPD.
Trends in electronic cigarette use in England Robert West Emma Beard Jamie Brown University College London
Smoking in England Robert West Jamie Brown University College London 1.
1 Behaviour change in theory and in real life Robert West University College London Stockholm, April 2008.
Characteristics and predictors of self-mutilation among adolescents in out of home group care in Taiwan Yu-Wen Chen Paper presented at the 2008 Association.
Acute exercise effects on craving and withdrawal symptoms among women attempting to quit smoking using nicotine replacement therapy Dr. Therese Harper.
1 Cancer Research UK smoking cessation programme at UCL: Robert West University College London London October 2007.
Webinar May 25th METHYLPHENIDATE FOR CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Date of download: 6/9/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Polygenic Risk and the Developmental Progression to.
1 Cytisine for smoking cessation Robert West John Stapleton Magda Cedzynska Paul Aveyard Witold Zatonski.
1 How best to motivate and help smokers to stop University College London November 2010 Robert West.
A Randomised Controlled Trial of Nicotine Replacement Therapy for Low-Income Smokers Valerie Sedivy, Caroline Miller and Jacqueline Hickling.
1 Should behavioural support for smoking cessation address wider psychological problems? University College London October 2013 Robert West.
Conclusions and Awards
Trends in electronic cigarette use in England
Assistant professor Family Medicine - Suez Canal University
Meta-analysis of Effectiveness of First-Line Smoking Cessation Pharmacotherapies 6 Months After Quitting Medication Estimated OR (95% CI) Est. abstinence.
Robert West University College London London March 2008
Smoking cessation in cardiac patients: the influence of action and coping plans and self-efficacy Natascha de Hoog¹, Catherine Bolman¹, Nadine Berndt¹,²,
Behavioural and pharmacological approaches to treating smokers
Nicotine replacement therapy
Trends in electronic cigarette use in England
Latest trends on smoking in England from the Smoking Toolkit Study
Alcohol, Other Drugs, and Health: Current Evidence May-June, 2018
EVITA Trial design: Smokers admitted with an acute coronary syndrome were randomized to varenicline 1 mg twice daily (n = 151) vs. placebo (n = 151). Study.
Hilary Millar, Val Reilly, Liz McGovern
Trends in electronic cigarette use in England
Helping younger smokers quit:
Presentation transcript:

Short-term efficacy of nicotine replacement therapy (NRT) for smoking cessation among adolescents and the role of compliance Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^ * Utrecht University, The Netherlands ^ Radboud University Nijmegen, The Netherlands

Introduction Nicotine dependence symptoms: – 60.9% of adolescents who ever smoked cigarettes daily had tried to quit smoking, but… only 12.2% were successful. Nicotine Replacement Therapy (NRT) as smoking cessation intervention

Introduction Meta-analysis (2011): – 6 RCTs Review (2012): – 9 RCTs, 1 lab-based study, 3 open-label studies Results: – Short-term (end-of-treatment): / – Mid-term (3-6 months):

Introduction Flaws – Small sample sizes (9 of 11: N < 135) – High drop-out – Low compliance (8-67%) no moderation effects condition smoking cessation compliance

(1) efficacy of NRT (nicotine patch) on short-term smoking cessation? (2) is the effect of NRT on smoking cessation moderated by patch use compliance? – 2a) can different trajectories of compliance be distinguished? – 2b) which factors predict different trajectories? (3) are there any (serious) adverse effects? Our study – Randomized Controlled Trial

Method Adolescents: N = 257, mean age 16.7 years, 53% female Information meeting 6/9 week treatment 6 online questionnaires 1)Age years 2)No major physical health problems 3)≥ 7 cigarettes per day 4)Parents aware of kids smoking behaviour 5)Motivated to quit smoking € 90

Outcome measures Smoking cessation (intent-to-treat) – abstinence after two weeks / end-of-treatment abstinence (prolonged abstinence) Compliance – number of days participants used the patches Adverse events – complaints concerning health / patch use Treatment period T5T4T6T1-T3 Abstinence after 2 weeks Week 1Week 2Week 3-6 End-of-treatment abstinence

Abstinence after two weeks End-of-treatment abstinence Results – Main effect + Moderation condition abstinence after 2 weeks compliance OR = 1.80*/2.02* OR = 1.12/1.12 condition OR = 0.83/0.79 abstinence at end of treatment compliance OR = 1.07 † /1.09*

Results – Percentages quitters Abstinence after 2 weeksEnd-of-treatment abstinence Placebo patch group21.3%13.1% Nicotine patch group31.9%14.8% 75915

Compliance Time Compliance Predictors

Results – Compliance trajectories (LCGA) Predictors -Age -Gender -Education -#CigPerDay -Previous quit att. -Impulsivity -Conscientiousness -Openness -Extraversion -Neuroticsm -Agreeableness -Condition Compliers: 34% Moderate decreasers: 16% Strong decreasers: 50% 23% 10% 9%

Results – adverse events Most reported adverse events In general more complaints in nicotine patch group (but scores max 2 out of 3)

Conclusion (1) Nicotine patches enhance abstinence rates after two weeks. (2) Nicotine patches enhance abstinence rates at end-of- treatment, but only among high-compliant adolescents. (2a,b) Higher number of previous quit attempts, higher level of conscientiousness and lower levels of extraversion were associated with higher levels of compliance. (3) No serious adverse events. Bgjsbel

Discussion Decline in compliance rates and abstinence rates from 2 weeks to end-of-treatment – Clinical relevance? Comparison with previous studies (our study: 14.8% abstinence at end-treatment) – 18% (PA, 2-week grace period, 12 weeks of treatment) – 28% (7-day PP, 8 weeks of treatment) – 28% (7-day PP, 10 weeks of treatment) Time-varying predictors for compliance trajectories

Implications So far, no convincing evidence of efficacy NRT for adolescents Interventions to enhance compliance Influence of (smoking) peers

“Interventions aimed at quitting smoking among adolescents are a waste of time (and money)”

Thank you for your attention Charlotte Scherphof

Introduction Percentage smoking adolescents (10-19 years) boys girls mean

Results - Short-term effects Condition Smoking cessation Compliance ConditionSmoking cessation Compliance